StockWatch
·

MYRIAD GENETICS INC

Ticker: 899923

P/L Snapshot

Q3 FY26 · consolidated

vs Q2 FY26·vs Q3 FY25
Revenue
202.70
+6.3%-1.5%
Expenditure
242.60
+5.7%+5.9%
Net Profit
-43.90
-1.6%-60.2%
OPM %
-19.68%
+0.71pp-8.36pp

Shareholding

Pattern breakdown

P/L Trends

(in millions)

RevenueExpenditureNet Profit
-435.24-164.67105.90376.47647.04Q3 FY23Q1 FY24Q2 FY24Q3 FY24Q1 FY25Q2 FY25Q3 FY25Q1 FY26Q2 FY26Q3 FY26
Price Chart
Latest News

Corporate Events

Board MeetingMYGN
2026
6Nov

Board Meeting

Executive Retention Stock Option Awards approved for certain…

SEC Filing ↗
Board MeetingMYGN
2026
4Nov

Board Meeting

Myriad Genetics, Inc. to hold its third quarter 2026 earning…

SEC Filing ↗
Board MeetingMYGN
2026
16Sep

Board Meeting

Vishal Sikri promoted to Executive Vice President - Commerci…

SEC Filing ↗
Board MeetingMYGN
2026
30Jul

Board Meeting

Second Quarter 2026 Earnings Conference Call and Business Up…

SEC Filing ↗
Board MeetingMYGN
2026
17Jun

Board Meeting

Director Resignation — Daniel M. Skovronsky M.D., Ph.D. resi…

SEC Filing ↗
Board MeetingMYGN
2026
4Jun

Board Meeting

Myriad Genetics Inc. held its 2026 Annual Meeting of Stockho…

SEC Filing ↗
Board MeetingMYGN
2026
1Jun

Board Meeting

CTO Appointment — Raj Jampa appointed as Chief Technology Of…

SEC Filing ↗